IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Zyversa Therapeutics Inc

CUSIP: 98987D201 | 11 institutional holders

Quarters

Q1 2024Q4 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Two Sigma Securities, LLC31,205
0.0% of portfolio›$23.4K
Cubist Systematic Strategies, LLC29,366
0.0% of portfolio›$22.0K
UBS Group AG19,909
0.0% of portfolio›$14.9K
HRT Financial LP13,176
0.0% of portfolio›$9
Jane Street Group, LLC12,120
0.0% of portfolio›$9.1K
Tower Research Capital LLC (TRC)8,542
0.0% of portfolio›$6.4K
Wells Fargo & Company11
0.0% of portfolio›$9
JPMorgan Chase & Co1
0.0% of portfolio›$1
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Two Sigma Securities, LLC
31,205$23.4K0.0%ValueVery HighNew York, NY2024-05-15
Cubist Systematic Strategies, LLC
29,366$22.0K0.0%ValueHighStamford, CT2024-05-15
UBS Group AG
19,909$14.9K0.0%CoreMediumZurich, Switzerland2024-05-13
HRT Financial LP
13,176$90.0%GARPVery HighNew York, NY2024-05-13
Jane Street Group, LLC
12,120$9.1K0.0%CoreVery HighNew York, NY2024-05-16
Tower Research Capital LLC (TRC)
8,542$6.4K0.0%GARPVery HighNew York, NY2024-05-15
Wells Fargo & Company
11$90.0%CoreLowSan Francisco, CA2024-05-10
JPMorgan Chase & Co
1$10.0%GrowthMediumNew York, NY2024-12-26
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-05-01